CAS: 3055-99-0; 3,6,9,12,15,18,21,24,27-Nonaoxanonatriacontan-1-Ol

该化合物是一种非离子表面活性剂,其特征是其水益聚乙烯甘醇链和缺水多丁基(C12尾尾),这种结构具有极佳的乳化,湿化和溶化特性,适合需要稳定的间活动的应用,其高含量的乙基氧化乙烯会提高水溶性和与极地溶剂的兼容性,而十二丁基链则能确保与缺水化合物的有效互动.该化合物经常用于需要受控水益的配方,如清洁剂,农用化学品和个人护理产品.其稳定性在一系列pH值和温度条件下,会进一步扩大其在工业和实验室环境中的用途.

结构式图片

相似化合物

19327-39-0 5274-63-5 618113-48-7

欧盟法规

欧盟化妆品法规附录三-限用物质清单ECHA物质ECHA物质C&L通报REACH预注册

上下游产品

CAS号112-27-6 三甘醇

合成工艺路线路线简述

    三乙二醇置于氯化亚砜,Sodium Hydride,三乙胺体系中,用 四氢呋喃,二氯甲烷 作为反应溶剂,化学反应 8.5H,反应生成 聚醚醇
    参考文献:单分散九聚乙二醇十二烷基醇单醚及其硫酸盐的制备方法和应用
    标题:单分散九聚乙二醇十二烷基醇单醚及其硫酸盐的制备方法和应用
    摘要:本发明公开了一种单分散九聚乙二醇十二烷基醇单醚及其硫酸盐的制备方法和应用,属于医药化工领域.从十二烷基醇出发,首先在碱的作用下通过与九聚乙二醇环硫酸酯的一次开环反应或通过与共含有九个乙二醇单元的多个寡聚乙二醇环硫酸酯的多次开环反应得到九聚乙二醇十二烷基醇单醚的硫酸盐;然后在硫酸的作用下水解得到九聚乙二醇十二烷基醇单醚.该方法可用于单分散聚乙二醇的长链烷基单醚及其硫酸盐的制备中.本发明以单一分子量聚乙二醇环硫酸酯为原料实现了六聚以上乙二醇的烷基醇单醚的高效合成,合成中没有用保护基,步骤简便,适于工业化生产,得到的产品相对于现有制备的聚桂醇具有明显的优势.

    海关参考信息

    专利信息


    专利号:US-2012190064-A1
    优先权日:2004-10-01
    标题 :Feeding buffers, systems, and methods for in vitro synthesis of biomolecules
    发明人:KUDLICKI WIESLAW ANTONI; KEPPETIPOLA SHIRANTHI; FLETCHER JULIA; GETBEHEAD ASHLEY ELAINE; KATZEN FEDERICO; VOZZA-BROWN LAURA
    权利人:KUDLICKI WIESLAW ANTONI; KEPPETIPOLA SHIRANTHI; FLETCHER JULIA; GETBEHEAD ASHLEY ELAINE; KATZEN FEDERICO; VOZZA-BROWN LAURA; LIFE TECHNOLOGIES CORP
    摘要:Compositions, methods and kits for in vitro systems for synthesis of biomolecules such as polypeptides, are provided herein. Cell extracts that provide enhanced yields of soluble proteins using in vitro protein synthesis methods are provided. The invention also includes methods for producing high yields of proteins by the addition of a feeding solution that includes amino acids and an energy source to an ongoing in vitro synthesis system. The invention also includes methods of using a high-yield in vitro synthesis system to produce large quantities of proteins with incorporated labeled amino acids for analysis by methods such as by NMR. The invention further includes vectors for enhanced production of proteins from nucleic acid templates using in vitro synthesis systems.

    专利号:WO-2004011474-A1
    优先权日:2002-07-31
    标题:Universal support media for synthesis of oligomeric compounds
    发明人:GUZAEV ANDREI P; MANOHARAN MUTHIAH; RAVIKUMAR VASULINGA T; KUMAR RAJU K
    权利人:ISIS PHARMACEUTICALS INC; GUZAEV ANDREI P; MANOHARAN MUTHIAH; RAVIKUMAR VASULINGA T; KUMAR RAJU K
    摘要:Compounds for the synthesis of oligomeric compounds, particularly oligonucleotide and oligonucleotide mimetics, are provided. In addition, methods for functionalizing a support medium with a first monomeric subunit and methods for the synthesis of oligomeric compounds utilizing the novel compounds bound to support media are provided.

    专利号:US-6653468-B1
    优先权日:2002-07-31
    标 题 :Universal support media for synthesis of oligomeric compounds
    发明人:GUZAEV ANDREI P; MANOHARAN MUTHIAH
    权利人:ISIS PHARMACEUTICALS INC
    摘要:Compounds for the synthesis of oligomeric compounds, particularly oligonucleotides and oligonucleotide mimetics, are provided. In addition, methods for functionalizing a support medium with a first monomeric subunit and methods for the synthesis of oligomeric compounds utilizing the novel compounds bound to support media are provided.

    专利号:WO-2024130393-A1
    优先权日:2022-12-21
    标 题 :Nanoparticle and method of synthesis thereof
    发明人:MOSKOVCHENKO SVITLANA
    权利人:MOSKOVCHENKO SVITLANA
    摘要:The present technology relates to nanoparticles, compositions comprising said nanoparticles, and methods of synthesis of said nanoparticles; wherein the nanoparticles comprise a metal nanoparticle core, a first coating of amphiphilic molecules, and a second coating of essential oil, essential oil primary constituent, or both, which combine the antimicrobial properties of metal nanoparticles, amphiphilic molecules, and essential oil or essential oil primary constituents.

    专利号:US-7282337-B1
    优先权日:2006-04-14
    标题:Methods for increasing accuracy of nucleic acid sequencing
    发明人:HARRIS TIMOTHY D
    权利人:HELICOS BIOSCIENCES CORP
    摘要:The invention provides methods for improving the accuracy of a sequencing-by-synthesis reaction by sequencing at least a portion of a template and at least a portion of template complementary sequence.

    专利号:US-2021008106-A1
    优先权日:2019-06-18
    标题 :Mitochondrial treatment of organs for transplantation
    发明人:PETERSEN THOMAS; HOGAN SARAH; ILAGAN ROGER; CLOER CARYN
    权利人:UNITED THERAPEUTICS CORP
    摘要:Methods and compositions relating to isolated mitochondria are disclosed. For example, cells, tissues, or organs can be treated with isolated mitochondria, such as porcine mitochondria, to improve mitochondrial function in the cell, tissue, or organ. The improvements to mitochondrial function include increased oxygen consumption and increased ATP synthesis. Such methods and compositions are useful for cell therapy; organ and tissue transplantation; organ and tissue engineering; and cold storage or shipment of harvested organs, tissues, and cells.
    南通辰润化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.chenrunchem.com
    电话: 0513-88743581👤
    📞南通辰润化工有限公司 ⚠️参考联系方式

    销售电话:0513-88743581
    邮箱:chenrunchem@sina.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    成都宇洋高科技发展有限责任公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.yygk.com
    电话: 0086-28-61777709👤
    📞成都宇洋高科技发展有限责任公司 ⚠️参考联系方式

    销售电话:0086-28-61777709
    邮箱:yygk@yygk.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.3350/kjhep.2011.17.2.152
    摘要:Kang HY, Lee WK, Kim YH, Kwon BW, Kang MS, Kim SB, Song IH. Ruptured duodenal varices arising from the main portal vein successfully treated with endoscopic injection sclerotherapy: a case report. Korean J Hepatol. 2011 Jun;17(2):152–6.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知